Z51.1 — Encounter for antineoplastic chemotherapy and immunotherapy
Is Z51.1 billable?
No — Z51.1 is a non-billable header code. Z51.1 groups more specific codes and cannot be submitted on a claim. A valid ICD-10-CM code must be reported at the highest level of specificity available in its branch. Select one of the 2 billable codes beneath Z51.1.
Billable codes under this header
Z51.1 at a glance
| Code | Z51.1 |
|---|---|
| Description | Encounter for antineoplastic chemotherapy and immunotherapy |
| Billable | No — header code |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Excludes2 — not included here
The conditions below are not part of Z51.1, but a patient may have both at the same time. When documentation supports it, Z51.1 and the excluded code may both be reported.
- encounter for chemotherapy and immunotherapy for nonneoplastic condition - code to condition
Excludes1 — never code together — inherited from Z51
The conditions below can never be reported together with Z51.1 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- follow-up examination after treatment (Z08-Z09)
Excludes2 — not included here — inherited from Z40-Z53
The conditions below are not part of Z51.1, but a patient may have both at the same time. When documentation supports it, Z51.1 and the excluded code may both be reported.
- follow-up examination for medical surveillance after treatment (Z08-Z09)
Code also — inherited from Z51
Two codes may be needed to describe the condition fully. Whether Z51.1 is sequenced first depends on the reason for the encounter.
- condition requiring care
What codes fall under Z51.1? (2)
How long has Z51.1 existed?
Z51.1 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.